From: Celiac disease and risk of myasthenia gravis – nationwide population-based study
Follow-up | HR; 95% CI | P-value | Observed vs. Expected | Person-years | Person-years Incidence ratea | Excess riska | Attributable percentage |
---|---|---|---|---|---|---|---|
Age (yrs) | |||||||
< 20 | 2.60; 0.50–13.60 | 0.257 | 2 vs 1 | 147,218 | 14 | 8 | 62 |
20–39 | 1.99; 0.40–9.92 | 0.402 | 2 vs 1 | 60,204 | 33 | 16 | 50 |
40–59 | 0.58; 0.07–4.58 | 0.602 | 1 vs 2 | 75,119 | 13 | −10 | −74 |
> =60 | 1.55; 0.33–7.37 | 0.581 | 2 vs 1 | 43,835 | 46 | 16 | 36 |
Sex | |||||||
Female | 2.28; 0.82–6.37 | 0.166 | 5 vs 2 | 204,000 | 24 | 14 | 56 |
Male | 0.79; 0.18–3.52 | 0.760 | 2 vs 3 | 122,376 | 16 | −4 | −26 |
Calendar period | |||||||
-1989 | 1.33; 0.27–6.48 | 0.726 | 1 vs 1 | 85,893 | 12 | 3 | 25 |
1990–99 | 1.16; 0.26–5.29 | 0.848 | 2 vs 2 | 161,814 | 12 | 2 | 14 |
2000- | 2.10; 0.57–7.66 | 0.264 | 3 vs 1 | 78,669 | 38 | 20 | 52 |